NCT06521567
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06521567
Title A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DNK | CZE

Facility Status City State Zip Country Details
GSK Investigational Site Los Angeles California 90048 United States Details
GSK Investigational Site Iowa City Iowa 52242 United States Details
GSK Investigational Site Hackensack New Jersey 07601 United States Details
GSK Investigational Site Cincinnati Ohio 45229 United States Details
GSK Investigational Site Providence Rhode Island 02903 United States Details
GSK Investigational Site Madison Wisconsin 53792 United States Details
GSK Investigational Site Brno 61300 Czechia Details
GSK Investigational Site Phaha 5 15006 Czechia Details
GSK Investigational Site Copenhagen 2100 Denmark Details
GSK Investigational Site Bordeaux 33076 France Details
GSK Investigational Site Lyon 69373 France Details
GSK Investigational Site Paris 75248 France Details
GSK Investigational Site Strasbourg 67098 France Details
GSK Investigational Site Villejuif 94805 France Details
GSK Investigational Site Bologna 40138 Italy Details
GSK Investigational Site Napoli 80123 Italy Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Madrid 28009 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field